RxDoctor Payments Data

Stephanie Canipe, NP

Adult Health · Morehead City, NCNPI 1871133850

Payments from drug & device makers

$1,327in general payments, 2019–2025

Across 71 payments — averaging $18.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$373
  • GSK$180
  • Novo Nordisk$144
  • Amgen$122
  • AbbVie$113
  • Organon$69
  • plus $326 from 12 others

What the payments were for

  • Food & beverage$1,327100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,327 in reported general payments places this provider in the 70th percentile of 614 adult health providers in North Carolina.

See all adult health providers in North Carolina

Medicare billing

Part B allowed, 2024
$80,464
Medicare patients
246
Services billed
1,336

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide39$53,608
RybelsusSemaglutide25$46,569
Trelegy ElliptaFluticasone/Umeclidin/Vilanter44$27,639
EliquisApixaban23$27,043
FarxigaDapagliflozin Propanediol14$18,845
JardianceEmpagliflozin16$18,315
TrulicityDulaglutide19$18,274
TrintellixVortioxetine Hydrobromide15$17,347
XareltoRivaroxaban16$17,226
JanuviaSitagliptin Phosphate14$15,547
MounjaroTirzepatide11$11,962
SymbicortBudesonide/Formoterol Fumarate37$9,755
Stiolto RespimatTiotropium Br/Olodaterol Hcl16$7,365
Bevespi AerosphereGlycopyrrolate/Formoterol Fum11$4,883
Atorvastatin Calcium327$4,164

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$144$100,17764 claims
AstraZenecaFarxiga, Symbicort, Bevespi Aerosphere$373$33,48362 claims
Lilly USA, LLCTrulicity, Mounjaro$29$30,23630 claims
GSKTrelegy Ellipta$180$27,63944 claims
PfizerEliquis$19$27,04323 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$16$17,34715 claims
MerckJanuvia$60$15,54714 claims
AbbVieSynthroid$113$3,12246 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 614 adult health providers in North Carolina.

Other adult health in Morehead City

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →